Advertisement
Advertisement

EPIX

EPIX logo

Essa Pharma Inc

1.62
USD
-0.025
-1.52%
Dec 18, 15:59 UTC -5
Closed
...

Essa Pharma Inc Profile

About

ESSA Pharma Inc. is a pharmaceutical company. The company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA Pharma Inc. is based in Vancouver, Canada.

Info & Links

CEO

David Parkinson

Headquarters

999 WEST BROADWAY, SUITE 720
VANCOUVER, A1 V5Z 1K5, CANADA

Auditor

DAVIDSON & COMPANY LLP

Share holders

--

Employees

50

Essa Pharma Inc Statistics

Valuation Measures

Market Capitalization2

71.66M

Enterprise Value

-14.33M

Enterprise Value/EBITDA(ttm)

0.42

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.56

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-20.17%

Return on Invested Capital(ttm)

-20.35%

Return on Assets(ttm)

-19.62%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-33.79M

Net Income Available to Common(ttm)

-27.67M

Diluted EPS(ttm)

-0.62

Share Statistics

Beta (5Y Monthly)

1.62

52-Week Change

-69.87%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

44.37M

Dividend Yield

0.00%

Float4

37.85M

% Held by Insiders

14.70%

% Held by Institutions

75.12%

Balance Sheet

Total Cash(mrq)

130.69M

Total Cash Per Share(mrq)

2.95

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

36.95%

Quick Ratio(mrq)

36.95%

Book Value Per Share(mrq)

2.90

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.44

Free Cash Flow(ytd)

-19.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement